FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A
- Written by PR Newswire
![]() |
- FDA's Fast Track designation speeds up the development of new biologic drugs for rare diseases
YONGIN, South Korea, June 10, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfilippo syndrome Type A) treatment, GC1130A.
This...
Read more: FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A















